The Role of RyR2 Mutations in Congenital Heart Diseases: Insights Into Cardiac Electrophysiological Mechanisms
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16569 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Tingting Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Mutation, Arrhythmias, Cardiac, Heart Defects, Congenital. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: This study was supported by National Natural Science Foundation of China (Grant No. 82100333), Beijing Tsinghua Changgung hospital Fund (Grant Nos. 12021C1007….
Abstract (Originalsprache)
Ryanodine receptor 2 (RyR2) protein, a calcium ion release channel in the sarcoplasmic reticulum (SR) of myocardial cells, plays a crucial role in regulating cardiac systolic and diastolic functions. Mutations in RyR2 and its dysfunction are implicated in various congenital heart diseases (CHDs). Studies have shown that mutations in the RYR2 gene, which encodes the RyR2 protein, are linked to several cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome (LQTS), calcium release deficiency syndrome (CRDS), and atrial fibrillation (AF). Additionally, RyR2 mutations have been associated with multiple genetic cardiomyopathies, such as left ventricular non‐compaction cardiomyopathy (LVNC), arrhythmogenic right ventricular cardiomyopathy (ARVC), hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Through various cell and animal models, researchers have developed mutant RyR2 models demonstrated that these mutations often lead to calcium dysregulation, typically resulting in either a gain or loss of function. This comprehensive review delves into the current understanding of RyR2 mutations and their impact on cardiac electrophysiology, focusing on the molecular mechanisms linking these mutations to arrhythmias and cardiomyopathies—an essential step in advancing diagnostic and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
ORCID-Profile: Tingting Lv, Ping Zhang
Förderung
- This study was supported by National Natural Science Foundation of China (Grant No. 82100333), Beijing Tsinghua Changgung hospital Fund (Grant Nos. 12021C1007…
Zitieren
APA
Lv, T., Li, S., Li, Q., Meng, L., Yang, J., Liu, L., Lv, C., & Zhang, P. (2025). The Role of RyR2 Mutations in Congenital Heart Diseases: Insights Into Cardiac Electrophysiological Mechanisms. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16569
Vancouver
Lv T, Li S, Li Q, Meng L, Yang J, Liu L, et al. The Role of RyR2 Mutations in Congenital Heart Diseases: Insights Into Cardiac Electrophysiological Mechanisms. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16569
BibTeX
@article{Lv2025,
author = {Lv, Tingting and Li, Siyuan and Li, Qing and Meng, Lingbing and Yang, Jing and Liu, Lianfeng and Lv, Changhua and Zhang, Ping},
title = {The Role of RyR2 Mutations in Congenital Heart Diseases: Insights Into Cardiac Electrophysiological Mechanisms},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16569}
}
EUVIMED